BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24525598)

  • 1. Effect of icodextrin on heart rate variability in diabetic patients on peritoneal dialysis.
    Orihuela O; de Jesús Ventura M; Ávila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Alcántara G; Lindholm B; García-López E; Villanueva C; Paniagua R
    Perit Dial Int; 2014; 34(1):57-63. PubMed ID: 24525598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
    Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
    Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Orihuela O; Prado-Uribe MD; Alcántara G; Amato D
    Perit Dial Int; 2009; 29(4):422-32. PubMed ID: 19602608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icodextrin metabolism and alpha-amylase activity in nonuremic rats undergoing chronic peritoneal dialysis.
    García-López E; Pawlaczyk K; Anderstam B; Qureshi AR; Kuzlan-Pawlaczyk M; Heimbürger O; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(4):415-23. PubMed ID: 17602150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH).
    de Moraes TP; Andreoli MC; Canziani ME; da Silva DR; Caramori JC; Ponce D; Cassi HV; de Andrade Bastos K; Rio DR; Pinto SW; Filho SR; de Campos LG; Olandoski M; Divino-Filho JC; Pecoits-Filho R
    Nephrol Dial Transplant; 2015 Nov; 30(11):1905-11. PubMed ID: 26063787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between ultrafiltrate volume with icodextrin and peritoneal transport pattern according to the peritoneal equilibration test.
    Araújo Teixeira MR; Pecoits-Filho RF; Romão Junior JE; Sabbaga E; Marcondes MM; Abensur H
    Perit Dial Int; 2002; 22(2):229-33. PubMed ID: 11990408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
    Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of high and low molecular weight molecules of icodextrin in plasma and dialysate, using gel filtration chromatography, in peritoneal dialysis patients.
    García-López E; Anderstam B; Heimbürger O; Amici G; Werynski A; Lindholm B
    Perit Dial Int; 2005; 25(2):181-91. PubMed ID: 15796147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Icodextrin: a review of its use in peritoneal dialysis.
    Frampton JE; Plosker GL
    Drugs; 2003; 63(19):2079-105. PubMed ID: 12962523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Icodextrin effluent leads to a greater proliferation than glucose effluent of human mesothelial cells studied ex vivo.
    Bajo MA; Selgas R; Castro MA; del Peso G; Diaz C; Sánchez-Tomero JA; Fernandez de Castro M; Alvarez V; Corbí A
    Perit Dial Int; 2000; 20(6):742-7. PubMed ID: 11216569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of peritoneal equilibrium test with icodextrin and 2.5% glucose dialysis solutions.
    Hwang JC; Wang HY; Wang CT; Chen HC
    J Nephrol; 2006; 19(6):758-63. PubMed ID: 17173249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.
    Posthuma N; ter Wee P; Donker AJ; Dekker HA; Oe PL; Verbrugh HA
    Perit Dial Int; 1999; 19(4):334-42. PubMed ID: 10507814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of a continuous ambulatory peritoneal dialysis (CAPD) technique with one icodextrin-containing and two biocompatible glucose-containing dialysates for preservation of residual renal function and biocompatibility in incident CAPD patients.
    Yoon HE; Chang YK; Shin SJ; Choi BS; Kim BS; Park CW; Song HC; Yoon SA; Jin DC; Kim YS
    J Korean Med Sci; 2014 Sep; 29(9):1217-25. PubMed ID: 25246739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized clinical trial to evaluate the effects of icodextrin on left ventricular mass index in peritoneal dialysis.
    Cordeiro L; Ishikawa WY; Andreoli MCC; Canziani MEF; Araujo LKRP; Pereira BJ; Abensur H; Moysés RMA; Elias RM
    Sci Rep; 2022 Sep; 12(1):15776. PubMed ID: 36138087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal accumulation of advanced glycosylation end-products in diabetic rats on dialysis with icodextrin.
    Lee JH; Reddy DK; Saran R; Moore HL; Twardowski ZJ; Nolph KD; Khanna R
    Perit Dial Int; 2000; 20 Suppl 5():S39-47. PubMed ID: 11229611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of icodextrin and glucose-containing solutions on insulin resistance in CAPD patients.
    Gürsu EM; Ozdemir A; Yalinbas B; Gürsu RU; Canbakan M; Güven B; Atasoyu EM; Keskin AT; Elçi A; Baru Y
    Clin Nephrol; 2006 Oct; 66(4):263-8. PubMed ID: 17063993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of icodextrin-based solutions on peritoneal transport in rats undergoing chronic peritoneal dialysis.
    Pawlaczyk K; Garcia-Lopez E; Kuzlan-Pawlaczyk M; Heimbürger O; Bergström J; Breborowicz A; Lindholm B
    Perit Dial Int; 2001; 21 Suppl 3():S359-61. PubMed ID: 11887855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome profile of peritoneal effluents in children on glucose- or icodextrin-based peritoneal dialysis.
    Bruschi M; Candiano G; Santucci L; Petretto A; Mangraviti S; Canepa A; Perri K; Ghiggeri GM; Verrina E
    Nephrol Dial Transplant; 2011 Jan; 26(1):308-16. PubMed ID: 20584736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.